A personal perspective on the science, ethics, and commercialization of xenotransplantation

Area of Science:

• * Biomedical Engineering
• * Transplantation Science
• * Xenotransplantation

Background:

• * A parent sought innovative treatments for a child's fatal lung disease, exploring both advanced pharmaceuticals and organ transplantation.
• * The primary challenge involved overcoming scientific, ethical, and commercialization hurdles associated with organ transplantation, particularly xenotransplantation.

Observation:

• * The parent's dedicated efforts over five years focused on enhancing the viability of pulmonary xenografts.
• * Significant progress was made, achieving a 100-fold increase in the duration pulmonary xenografts remained viable.

Findings:

• * Pulmonary xenografts demonstrated a 100-fold increase in viability hours due to the parent's interventions.
• * Despite advancements, xenotransplantation for this application has not yet reached commercial viability.

Implications:

• * The research highlights the potential of xenotransplantation in addressing organ shortages but underscores the need for further development.
• * Ongoing ethical considerations and the pursuit of commercial viability remain critical areas for future research and policy.
• * The study provides valuable insights into the long-term viability challenges of pulmonary xenografts.